Image from Google Jackets

Acute myeloid leukemia : signssymptoms, classification, and treatment options [E-Book]

Contributor(s): Series: Cancer etiology, diagnosis, and treatmentsPublisher: New York : Nova Biomedical, [2015]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781634839181
  • 1634839188
Subject(s): Online resources:
Contents:
ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 CLINICAL PRESENTATION OF ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; INCIDENCE AND PATIENT CHARACTERISTICS ; SYMPTOMS ; ORGAN INVOLVEMENT ; Skin ; Ocular ; Oral ; Central Nervous System ; Cardiovascular ; Pulmonary ; Gastrointestinal ; Lymphoreticular ; Musculoskeletal ; LABORATORY FINDINGS ; Complete Blood Counts ; Coagulation Studies
Electrolytes Leukocyte Larceny ; CLINICAL SYNDROMES ASSOCIATED WITH AML; Leukostasis ; Disseminated Intravascular Coagulation ; Tumor Lysis Syndrome ; Infection ; Extramedullary Disease ; CONCLUSION ; REFERENCES ; Chapter 2 PROGNOSIS OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; Subtypes of CBF AML ; Clinical Prognostic Factors ; Molecular Prognostic Factors ; Cytogenetic Factors ; Minimal Residual Disease ; Other Factors ; CONCLUSION AND FUTURE PERSPECTIVES ; ACKNOWLEDGMENTS; REFERENCES; Chapter 3 PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA
ABSTRACT INTRODUCTION; Differentiating from Blast Phase Chronic Myeloid Leukemia ; ClinicopathologicFeatures ; Management ; Role of Chemotherapy ; Role of Tyrosine Kinase Inhibitors ; Allogeneic Stem Cell Transplantation ; Presence of Additional Abnormalities ; CONCLUSION ; CONFLICT OF INTEREST ; ACKNOWLEDGMENT ; REFERENCES ; Chapter 4 THERAPY OF OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA; ABSTRACT ; INTRODUCTION ; PROGNOSTIC FACTORS; Patient-Related Prognostic Factors ; Age ; Performance Status ; Comorbidities ; Other Patient-Related Prognostic Factors; Disease-Related Prognostic Factors
WBC Count Cytogenetics ; Molecular Genetics ; Mutations ; Overexpression ; Multidrug Resistance ; Secondary AML ; Other Disease Related Prognostic Factors ; Response-Related Prognostic Factors ; TREATMENT ; Intensive Induction Chemotherapy; The Role of Cytarabine ; The Role of Anthracycline ; The Role of Other Cytotoxic Agents ; The Role of Gemtuzumab Ozogamicin ; The Role of Multidrug Resistance Modulators ; The Role of Growth Factors ; Non-Intensive Induction Chemotherapy ; The Role of BSC ; The Role of Low Dose Cytarabine (LDAC) ; The Role of Clofarabine
The Role of Hypomethylating Agents Azacitidine ; Decitabine ; Postremission Chemotherapy ; CONCLUSION; REFERENCES ; INDEX
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record.

ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; ACUTE MYELOID LEUKEMIA SIGNS/SYMPTOMS, CLASSIFICATION AND TREATMENT OPTIONS ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 CLINICAL PRESENTATION OF ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; INCIDENCE AND PATIENT CHARACTERISTICS ; SYMPTOMS ; ORGAN INVOLVEMENT ; Skin ; Ocular ; Oral ; Central Nervous System ; Cardiovascular ; Pulmonary ; Gastrointestinal ; Lymphoreticular ; Musculoskeletal ; LABORATORY FINDINGS ; Complete Blood Counts ; Coagulation Studies

Electrolytes Leukocyte Larceny ; CLINICAL SYNDROMES ASSOCIATED WITH AML; Leukostasis ; Disseminated Intravascular Coagulation ; Tumor Lysis Syndrome ; Infection ; Extramedullary Disease ; CONCLUSION ; REFERENCES ; Chapter 2 PROGNOSIS OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA ; ABSTRACT ; INTRODUCTION ; Subtypes of CBF AML ; Clinical Prognostic Factors ; Molecular Prognostic Factors ; Cytogenetic Factors ; Minimal Residual Disease ; Other Factors ; CONCLUSION AND FUTURE PERSPECTIVES ; ACKNOWLEDGMENTS; REFERENCES; Chapter 3 PHILADELPHIA CHROMOSOME-POSITIVE ACUTE MYELOID LEUKEMIA

ABSTRACT INTRODUCTION; Differentiating from Blast Phase Chronic Myeloid Leukemia ; ClinicopathologicFeatures ; Management ; Role of Chemotherapy ; Role of Tyrosine Kinase Inhibitors ; Allogeneic Stem Cell Transplantation ; Presence of Additional Abnormalities ; CONCLUSION ; CONFLICT OF INTEREST ; ACKNOWLEDGMENT ; REFERENCES ; Chapter 4 THERAPY OF OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA; ABSTRACT ; INTRODUCTION ; PROGNOSTIC FACTORS; Patient-Related Prognostic Factors ; Age ; Performance Status ; Comorbidities ; Other Patient-Related Prognostic Factors; Disease-Related Prognostic Factors

WBC Count Cytogenetics ; Molecular Genetics ; Mutations ; Overexpression ; Multidrug Resistance ; Secondary AML ; Other Disease Related Prognostic Factors ; Response-Related Prognostic Factors ; TREATMENT ; Intensive Induction Chemotherapy; The Role of Cytarabine ; The Role of Anthracycline ; The Role of Other Cytotoxic Agents ; The Role of Gemtuzumab Ozogamicin ; The Role of Multidrug Resistance Modulators ; The Role of Growth Factors ; Non-Intensive Induction Chemotherapy ; The Role of BSC ; The Role of Low Dose Cytarabine (LDAC) ; The Role of Clofarabine

The Role of Hypomethylating Agents Azacitidine ; Decitabine ; Postremission Chemotherapy ; CONCLUSION; REFERENCES ; INDEX

Master record variable field(s) change: 050, 082

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice